ArticlePloS one2024

Decreased risk of underdosing with continuous infusion versus intermittent administration of cefotaxime in patients with sickle cell disease and acute chest syndrome.

Keyvan Razazi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.